Possibilities of using contrast-enhanced ultrasound in formation of virtual dynamic nephroscintigraphy protocol in patients with type II diabetes mellitus
https://doi.org/10.33667/2078-5631-2022-13-32-37
Abstract
Objective. To evaluate the effectiveness of contrast-enhanced ultrasound in the formation of the protocol of virtual dynamic nephroscintigraphy in patients with type 2 diabetes mellitus.
Materials and methods. All patients were examined according to a single diagnostic algorithm, which included four stages: 1) multiparametric ultrasound examination of the kidneys in the In-mode; 2) Doppler assessment of the state of intrarenal blood flow in this group of patients; 3) carrying out CEUS of the kidneys in accordance with European recommendations for clinical practice on contrast-enhanced ultrasound examination followed by the calculation of virtual dynamic nephroscintigraphy; 4) carrying out dynamic nephroscintigraphy according to standard the methodology as a reference method.
Results. In the course of the study, patients (n = 32) with a clinical diagnosis of type 2 diabetes mellitus of varying severity were examined. All patients were divided into 2 groups of 16 people each, depending on the results of glomerular filtration rate (GFR). The time of maximum accumulation of contrast agent in group 1 (patients with type 2 diabetes and GFR greater than 60 ml/min/1.73 m2) is quantitatively less than in group 2 (patients with type 2 diabetes and GFR 30–44 ml/min/1.73 m2). The half-life of the contrast agent in groups 1 and 2 does not change significantly. When performing virtual dynamic nephroscintigraphy in patients of the 1st and 2nd groups, the results correlating with the reference method – dynamic nephroscintigraphy were obtained.
Conclusion. The method of using contrast-enhanced ultrasound in the formation of the protocol of virtual dynamic nephroscintigraphy in patients with type 2 diabetes mellitus allows us to obtain quantitative indicators of dynamic nephroscintigraphy for subsequent medical conclusions, as well as the possibility of dynamic monitoring of the course of the disease without the use of ionizing research methods.
About the Authors
A. V. Borsukov
Smolensk State Medical University
Russian Federation
Russian Federation
Borsukov Alexey V., DM Sci (habil.), professor, head of fundamental research laboratory ‘Diagnostic researches and minimally invasive technologies’
Smolensk
O. A. Gorbatenko
Smolensk State Medical University
Russian Federation
Russian Federation
Gorbatenko Olga A., post-graduate student of fundamental research laboratory ‘Diagnostic researches and minimally invasive technologies’
Smolensk
References
1. International Diabetes Federation, 2019. URL: https://www.idf.org
2. Practical recommendations of KDIGO for diagnosis, prevention and treatment of mineral and bone disorders in chronic kidney disease (CKD-MCD). Summary of recommendations. Nephrology 2011; 15 (1): 88–95. (In Russ.)
3. Sergienko V.B. [et al.] Methodological recommendations. Perfusion scintigraphy and myocardial SPECT. Cardiological Bulletin. 2015. V. 10. No. 2. P. 6–21. (In Russ.)
4. James A. Sheiman. Pathophysiology of the Kidney. Transl. from English – M.: Publishing House BINOM, P. 2019–192. (In Russ.)
5. Ultrasound examination using contrast agents. From simple to complex. Under total. Ed. A.N. Sencha. M.: MEDpress-inform, 2021. 296.: ill. ISBN987-5-00030-862-2. (In Russ.)
6. Claudon M., Dietrich C. F., Choi B. I., Cosgrove D. O., Kudo M., Nolsoe C. P., Piscaglia F., Wilson S.R., Barr R.G., Chammas M.C., Chaubal N.G., Chen M.H., Clevert D.A., Correas J.M., Ding H., Forsberg F., Fowlkes J.B., Gibson R.N., Goldberg B.B., Lassau N., Leen E.L., Mattrey R.F., Moriyasu F., Solbiati L., Weskott H.P., Xu H. X. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013. V. 34. No. 1. P. 11–29. DOI: 10.1055/s-0032–1325499.
7. Weskott H.-P. Contrast sonography. 1st ed. Bremen: UNI–MED, 2014. 284 p. (In Russ.)
8. Lishmanov Yu.B., Chernov V.I. National Guidelines for radionuclide diagnostics, edited by Yu.B. Lishmanov, V.I. Chernov. Yu.B. Lishmanov, V.I. Chernov, Tomsk.: STT. 2010. P. 418. (In Russ.)
9. Bertolotto M. Color Doppler sonographic appearance of renal perforating vessels in subjects with normal and impaired renal function. M. Bertolotto, E. Quaia, G. Galli et al. Journal of Clinical Ultrasound. 2000. Vol. 28, No. 6. P. 267–276.
10. Sidhu P.S., Cantisani V., Dietrich C.F., Gilja O.H., Saftoiu A., Bartels E. et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018; 39 (2): e2–e44. DOI: 10.1055/a-0586–1107.
11. Westwood M., Joore M., Grutters J., Redekop K., Armstrong N., Lee K. et al. Contrast-enhanced ultrasound using SonoVue® (sulfur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterization of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2013; 17 (16): 1–243. DOI: 10.3310/hta17160.
12. Claudon M., Dietrich C.F., Choi B.I., Cosgrove D.O., Kudo M., Nolsoe C.P. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013; 34 (1): 11–29. DOI: 10.1055/s-0032–1325499.
13. Order on the Regulation of the Use of Radioisotope Products in Healthcare institutions of April 23, 1999, No. 144. URL: http://docs.cntd.ru/document/901733724 (In Russ.)
14. Borsukov A. V. Contrast-enhanced ultrasound of the liver: the evolution of world experts’ assessments from 2012 to 2020. Oncological journal: radiation diagnostics, radiation therapy. 2021; 4 (1): 20–30. DOI: 10.37174/2587-7593-2021-4-1-20-30. (In Russ.)
Review
For citations:
Borsukov A.V., Gorbatenko O.A. Possibilities of using contrast-enhanced ultrasound in formation of virtual dynamic nephroscintigraphy protocol in patients with type II diabetes mellitus. Medical alphabet. 2022;(13):32-37. (In Russ.) https://doi.org/10.33667/2078-5631-2022-13-32-37
Views:
203
Email this article 